Skip to main content
CLVT
NYSE Technology

Clarivate Reports Significant Share Repurchases and No New Goodwill Impairments in 2025 Annual Report

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$1.74
Mkt Cap
$1.111B
52W Low
$1.66
52W High
$4.98
Market data snapshot near publication time

summarizeSummary

The 2025 annual report for Clarivate PLC presents a mixed but overall positive outlook, primarily driven by robust capital allocation and signs of financial stabilization. The company executed substantial share repurchases totaling $224.5 million in 2025, representing over 20% of its current market capitalization, with $275.5 million remaining under the current $500 million authorization. This demonstrates a strong commitment to shareholder returns, especially with the stock trading near its 52-week lows. A key positive is the absence of any goodwill impairment charges in 2025, following significant impairments in the prior two years, suggesting a stabilization of asset values. Furthermore, the company reported effective internal controls over financial reporting and a positive development in its ongoing securities class action lawsuit, with the court dismissing the second amended complaint without prejudice. While overall revenues declined by 4% in 2025, the company achieved 1.8% organic annualized contract value (ACV) growth, indicating a strategic shift towards recurring revenue streams through its "Value Creation Plan." Investors should monitor the execution of this plan and future revenue trends, but the current report provides strong signals of financial health and management confidence.


check_boxKey Events

  • Significant Share Repurchases

    The company repurchased $224.5 million of ordinary shares in 2025 at an average price of $4.01 per share, with $275.5 million remaining under the current $500 million authorization. This represents a substantial return of capital to shareholders.

  • No Goodwill Impairment in 2025

    After recording significant goodwill and intangible asset impairments in 2023 and 2024, Clarivate reported no new impairment charges in 2025, indicating a stabilization of asset valuations.

  • Debt Management & Liquidity

    Clarivate redeemed $600 million in Senior Secured Notes in 2025 and an additional $100 million in January 2026, while increasing its revolving credit facility to $775 million, enhancing financial flexibility.

  • Effective Internal Controls

    Management and external auditors concluded that internal control over financial reporting was effective as of December 31, 2025, a positive for compliance and investor confidence.


auto_awesomeAnalysis

The 2025 annual report for Clarivate PLC presents a mixed but overall positive outlook, primarily driven by robust capital allocation and signs of financial stabilization. The company executed substantial share repurchases totaling $224.5 million in 2025, representing over 20% of its current market capitalization, with $275.5 million remaining under the current $500 million authorization. This demonstrates a strong commitment to shareholder returns, especially with the stock trading near its 52-week lows. A key positive is the absence of any goodwill impairment charges in 2025, following significant impairments in the prior two years, suggesting a stabilization of asset values. Furthermore, the company reported effective internal controls over financial reporting and a positive development in its ongoing securities class action lawsuit, with the court dismissing the second amended complaint without prejudice. While overall revenues declined by 4% in 2025, the company achieved 1.8% organic annualized contract value (ACV) growth, indicating a strategic shift towards recurring revenue streams through its "Value Creation Plan." Investors should monitor the execution of this plan and future revenue trends, but the current report provides strong signals of financial health and management confidence.

في وقت هذا الإيداع، كان CLVT يتداول عند ‏١٫٧٤ US$ في NYSE ضمن قطاع Technology، مع قيمة سوقية تقارب ١٫١ مليار US$. تراوح نطاق التداول خلال 52 أسبوعًا بين ‏١٫٦٦ US$ و‏٤٫٩٨ US$. تم تقييم هذا الإيداع على أنه ذو معنويات سوقية إيجابية وبدرجة أهمية ٨ من 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CLVT - Latest Insights

CLVT
Apr 29, 2026, 6:11 AM EDT
Source: Reuters
Importance Score:
7
CLVT
Apr 29, 2026, 6:06 AM EDT
Filing Type: 10-Q
Importance Score:
7
CLVT
Apr 01, 2026, 8:06 AM EDT
Filing Type: DEFA14A
Importance Score:
7
CLVT
Apr 01, 2026, 7:56 AM EDT
Filing Type: DEF 14A
Importance Score:
7
CLVT
Mar 26, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
7
CLVT
Feb 24, 2026, 6:04 AM EST
Filing Type: 10-K
Importance Score:
8
CLVT
Feb 24, 2026, 6:03 AM EST
Filing Type: 8-K
Importance Score:
9
CLVT
Feb 06, 2026, 7:25 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
CLVT
Feb 02, 2026, 7:42 AM EST
Filing Type: 8-K
Importance Score:
9